Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fortress Biotech Q2 EPS $(0.73) Beats $(1.23) Estimate, Sales $14.90M Beat $14.77M Estimate

Author: Benzinga Newsdesk | August 13, 2024 04:57pm
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(1.23) by 40.65 percent. This is a 80 percent increase over losses of $(3.65) per share from the same period last year. The company reported quarterly sales of $14.90 million which beat the analyst consensus estimate of $14.77 million by 0.83 percent. This is a 14.32 percent decrease over sales of $17.39 million the same period last year.

Posted In: FBIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist